The prognosis of glioblastomas is still extremely poor and the discovery of novel molecular therapeutic targets can be important to optimize treatment strategies. Gene expression analyses comparing normal and neoplastic tissues have been used to identify genes associated with tumorigenesis and potential therapeutic targets. We have used this approach to identify differentially expressed genes between primary glioblastomas and non-neoplastic brain tissues. We selected 20 overexpressed genes related to cell cycle, cellular movement and growth, proliferation and cell-to-cell signaling and analyzed their expression levels by real time quantitative PCR in cDNA obtained from microdissected fresh tumor tissue from 20 patients with primary glioblas...
As many as 100,000 new cases of brain tumor are diagnosed each year in the United States. About half...
International audiencePurpose: Glioblastomas (GBM) are highly malignant and heterogeneous gliomas wi...
Diagnosis and classification of gliomas mostly relies on histopathology and a few genetic markers. H...
The prognosis of glioblastomas is still extremely poor and the discovery of novel molecular therapeu...
The gene expression pattern of glioblastoma (GBM) is well documented but the expression profile of b...
The gene expression pattern of glioblastoma (GBM) is well documented but the expression profile of b...
Glioblastoma (GBM) is both the most common and the most lethal primary brain tumor. It is thought th...
The gene expression pattern of glioblastoma (GBM) is well documented but the expression profile of b...
peer reviewedIn the present study, we have used the gene expression data available in the SAGE datab...
The molecular heterogeneity of gene expression profiles of glioblastoma multiforme (GBM) are the mos...
Legal entity responsible for the study: CHU de Limoges - Hôpital DupuytrenInternational audienceBack...
Legal entity responsible for the study: CHU de Limoges - Hôpital DupuytrenInternational audienceBack...
Glioma is the most common neoplasm of the central nervous system (CNS); the progression and outcomes...
Gliomas are among the most aggressive malignant tumors and the most refractory to therapy, in part d...
International audiencePurpose: Glioblastomas (GBM) are highly malignant and heterogeneous gliomas wi...
As many as 100,000 new cases of brain tumor are diagnosed each year in the United States. About half...
International audiencePurpose: Glioblastomas (GBM) are highly malignant and heterogeneous gliomas wi...
Diagnosis and classification of gliomas mostly relies on histopathology and a few genetic markers. H...
The prognosis of glioblastomas is still extremely poor and the discovery of novel molecular therapeu...
The gene expression pattern of glioblastoma (GBM) is well documented but the expression profile of b...
The gene expression pattern of glioblastoma (GBM) is well documented but the expression profile of b...
Glioblastoma (GBM) is both the most common and the most lethal primary brain tumor. It is thought th...
The gene expression pattern of glioblastoma (GBM) is well documented but the expression profile of b...
peer reviewedIn the present study, we have used the gene expression data available in the SAGE datab...
The molecular heterogeneity of gene expression profiles of glioblastoma multiforme (GBM) are the mos...
Legal entity responsible for the study: CHU de Limoges - Hôpital DupuytrenInternational audienceBack...
Legal entity responsible for the study: CHU de Limoges - Hôpital DupuytrenInternational audienceBack...
Glioma is the most common neoplasm of the central nervous system (CNS); the progression and outcomes...
Gliomas are among the most aggressive malignant tumors and the most refractory to therapy, in part d...
International audiencePurpose: Glioblastomas (GBM) are highly malignant and heterogeneous gliomas wi...
As many as 100,000 new cases of brain tumor are diagnosed each year in the United States. About half...
International audiencePurpose: Glioblastomas (GBM) are highly malignant and heterogeneous gliomas wi...
Diagnosis and classification of gliomas mostly relies on histopathology and a few genetic markers. H...